###### Strengths and limitations of this study

-   One strength is that we will conduct a comprehensive, exhaustive search strategy with an experienced research team.

-   Another strength of this study is the novelty of the research question: barriers to quality HIV-care among Francophone and French-speaking African, Caribbean and Black (ACB) immigrant people living with HIV in Canada.

-   One limitation is that it is unlikely that we will find experimental studies.

-   Another limitation of this scoping review is that it will be focused only on Canada and therefore its global relevance is limited; however, theoretical generalisations can be postulated and tested with Francophone diaspora minorities in predominantly anglophone communities.

-   Significance of the study: This scoping review will answer important questions related to access to care for Francophone HIV-infected ACB living in Canada. Furthermore, this review will evaluate the impact of intersectionality of the French language, race and HIV stigma on ACB accessibility to HIV care. The findings of this scoping systematic review will have implications for health policy and practice in the provision of care to Francophone HIV-infected and affected ACB immigrants and Canadians.

Introduction {#s1}
============

It is well-established that language is more than a translation of words.[@R1] In Canada, the term 'minority Francophone' refers to people living outside of the province of Quebec in majority English speaking provinces and whose mother tongue or first official language spoken is French.[@R2] Francophone individuals represent approximately 5% of the Ontario population.[@R3] The Francophone population now includes immigrants from African countries with French as their official language.[@R2] Almost 7.5% of Francophone in Ontario speak French only, regardless of their mother tongue.[@R3] Therefore African, Caribbean and Black (ACB) people who identify French as their primary language, represent a growing segment of the Francophone population in Ontario.

The French Language Service Act, 1986 [@R5] guarantees the right of individuals to receive French-language services from the Ontario government ministries and agencies, including access to French healthcare services. However, providing high quality French healthcare services remains a challenge across the province of Ontario and other English speaking provinces in Canada.[@R4] A study done in New Brunswick, the only official bilingual province in Canada, has shown that francophone individuals are less likely to report their health as being 'good' compared with their Anglophone-majority counterparts.[@R10] Other studies have reported that the quality of French healthcare services in Canadian Anglophone provinces is suboptimal.[@R4]

In the USA, language barriers and immigration status have been identified as barriers to HIV testing for new immigrants from sub-Saharan Africa and the Caribbean.[@R13] Immigrants, once healthy when compared with their Canadian-born counterparts, have self-reported poor health associated with language barriers, discrimination and immigration status.[@R14] In some places, the quality of French healthcare services has resulted in avoidance of care by the francophone living in anglophone-majority provinces.[@R16] In 2016, the Public Health Agency of Canada reported that an estimated 36 319 people were living with HIV (PLWH) in Ontario, with about one third of them from the ACB communities.[@R17] Social determinants of health such as language barriers, stigma and discrimination have negative consequences on linkage and engagement to care for HIV positive immigrants and ACB in Ontario,[@R4] and may be worse in ACB Francophone minorities. The core of any community services providing support to PLWH is health promotion, quality of care, counselling and preventive care as well as case management and patient satisfaction.[@R18]

The purpose of this systematic scoping review is to inform policy makers, community health centres and HIV organisations on the outcomes associated with being a Francophone minority living with HIV in Canada. The primary objective of this scoping systematic review is to document access to health services by French-speaking people living with HIV in Canada. The secondary objective is to assess the state of the HIV-care continuum for Francophone ACB people living with HIV in Canada. HIV-care continuum or cascade includes the following: HIV diagnosis, linkage and retention to care, receipt of antiretroviral therapy (ART) and achievement of viral suppression.[@R20] We will also summarise data on participation in health promotion, finding a regular provider, receiving preventive care, satisfaction with care, the effects of race, stigma and discrimination, including immigration status.

Methods and analyses {#s2}
====================

We will adopt the scoping review approach proposed by Peterson *et al* that ensures that the review is executed such that it can inform practice, policy, education and research.[@R21] The scoping review approach is different from the standard systematic review in that we will not attempt to answer a specific research question, but rather appraise a broad body of evidence in order to describe HIV care for French-speaking people living with HIV in Canada. HIV-care continuum or cascade includes the following: HIV diagnosis, linkage and retention to care, receipt of ART and achievement of viral suppression.

Patient and public involvement {#s2a}
------------------------------

Patients and public will not be involved in the study.

Inclusion criteria for studies {#s2b}
------------------------------

### Types of studies {#s2b1}

We will consider experimental (randomised or non-randomised) and observational studies (longitudinal, cross-sectional), evidence syntheses (systematic reviews) and qualitative or mixed-method studies.

For a study to be eligible, it must include data on French-speaking people with HIV in an anglophone-majority Canadian province and address at least one of the outcomes of interest. Studies from Quebec will be excluded.

Outcomes {#s2c}
--------

Our primary outcome is the quality of and access to health services for francophones living with HIV in anglophone-majority provinces in Canada. We will look at the HIV-care cascade which includes HIV diagnosis, linkage and retention to care, receipt of ART and achievement of viral suppression.

### Our secondary outcomes {#s2c1}

The secondary outcomes will focus on the participation of Canadian Francophone ACB PLWH in health promotion, their proximity to healthcare centres and quality of life. We will extract data on the quality of care provided to this population as well as the effect of race, stigma and discrimination on care provided. Furthermore, we will also collect data on access of Francophone ACB PLWH to bilingual healthcare providers and preventive care and patient satisfaction.

Search strategy for identification of studies {#s2d}
---------------------------------------------

We will conduct an exhaustive search for published studies in English and French reporting on health and healthcare in francophone populations in Canada. The search will include the search terms listed in [box 1](#B1){ref-type="boxed-text"} and will be adapted for each database ([box 1](#B1){ref-type="boxed-text"}).Box 1Proposed search strategy for MEDLINEDatabase: MEDLINESearch strategy:exp 'Emigrants and Immigrants'/immigrant\*.mp.Emigrant\*.mp.migrant\*.mp.(landed adj5 status).tw.(landed adj5 person\*).tw.(landed adj5 resident\*).tw.exp Refugees/asylum.tw.new Canadian.tw.resident.tw.refugee.tw.\*POPULATION/communit\*.tw.exp MINORITY GROUPS/MINORITY HEALTH/minorit\*.tw.exp patient/or patient.tw.1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17french.tw.francophone\*.tw.Francophonie.mp.exp Language/(french or francais or franco\* or quebec\*).tw.23 and 24((french or francais or franco\*) adj5 language).tw.20 or 21 or 22 or 25 or 26exp African Continental Ancestry Group/(Africa\* or African or Afrique or Africain\*).tw.Benin.tw.Burkina Fas\*.tw.Burundi.tw.Cameroon.tw.'Central African Republic'.tw.Centrafrique.tw.centrafricain\*.tw.Caribbean.mp. or exp Caribbean Region/exp CHAD/(Congo or congol\*).tw.Brazzaville.tw.Kinshasa.tw.Djibouti.tw.Guinea.tw.French africa.tw.Gabon\*.tw.Haiti\*.tw.(Ivory Coast or Ivoire or Ivorian).tw.Madagascar.tw.Mali.tw.Morroc\*.tw.Niger.tw.Rwanda\*.tw.(St? Martin or saint Martin).tw.Senegal\*.tw.Togo.tw.Black-White.tw.Black.ti,ab.'black canadian'.tw.mixed race.tw.27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 58 or 5919 and 60canada/(Canada or Canad\*).tw.(canada or or or or or or or or canadian\$ or alberta or british columbia or columbie britannique).tw.(saskatchewan or manitoba or ontario or quebec or new brunswick or nouveau brunswick).tw.(nova scotia or nouvelle ecosse or prince edward island or ile du prince edward or newfoundland or terre neuve or labrador or nun?v?t or nun?v?t or nwt or territoires du nord ouest or northwest territories or yukon).tw.OHIP.tw.'health canada'.tw.'sante canada'.tw.medicare.tw.CIHR.tw.('Alberta Health Care Insurance Plan' or AHCIP).tw.('Medical Services Plan' or MSP).tw.Manitoba health.tw.('Vitalite Health Network' or 'Horizon Health Network').tw.'Department of Health and Community Services'.tw.'Health Care Card'.tw.('Nova scotia health card' or MSI).tw.Nunavut Health Insurance Card.tw.('Carte d'assurance maladie' or 'Health Insurance Card' or 'RAMQ').tw.(health card adj25 canada).tw.62 or 63 or 64 or 65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 8161 and 82exp 'Delivery of Health Care'/proximity.ti,ab.'healthcare or health care'.tw.exp Health Care Quality, Access/and Evaluation/Quality of care/Health Promotion/Primary Health Care/Patient Acceptance of Health Care/Healthcare Disparities/exp racism/multilingualism/Needs Assessment/exp Culturally Competent Care/Health Services Accessibility/exp Physicians, Family/quality indicators/Patient Medication Knowledge/Patient Navigation/Patient Compliance/exp patient satisfaction/exp HIV/Preventive Medicine/HIV.mp.exp HIV infections/seropositivity/seroconversion/Quality of Life/(HRQOL or karnofsky).tw.84 or 86 or 87 or 90 or 91 or 92 or 95 or 96 or 97 or 98 or 100 or 101 or 102 or 104 or 10619 and 27 and 60 and 83 and 112

Electronic searches {#s2e}
-------------------

We will conduct our searches in MEDLINE, Excerpta Medica Database, Cumulative Index to Nursing and Allied Health Literature, Web of Science, EBSCO and Google Scholar from 1990 (date that the French Language Service Act was enacted in Ontario) to 2018.[@R5] We will use specific search terms in various combinations. The search will be conducted by a health sciences librarian at the Scotia Bank Health Sciences library at St. Michael's Hospital.

Reference lists {#s2f}
---------------

The reference lists of all relevant citations will be searched for available related articles.

Grey literature {#s2g}
---------------

We will search for available theses and reports. Furthermore, experts, authors and relevant organisations such as African and Caribbean Council on HIV/AIDS in Ontario, Association Francophone pour le Savoir, The Ontario HIV Treatment Network and CATIE (Canada's source for HIV and hepatitis C information) will be contacted.

Data collection and analyses {#s2h}
----------------------------

Data will be collected from each study independently and in duplicate by PD and JN. We will extract data from eligible studies such as publication details, study design, sample populations, outcomes measured and specific barriers.

Screening {#s2i}
---------

We will import all citations obtained using the search strategy into DistillerSR to facilitate study screening and selection and de-duplication of citations prior to undertaking the abstract review. DistillerSR will also allow screeners to check each other's work.

A customised form reflecting the previously described inclusion criteria will be pilot- tested by two reviewers. Specifically, the data collection form will be developed and applied by two reviewers independently to a sample of 50 abstracts to ensure consistency of use and clarity of the instrument. Cohen's kappa statistic[@R22] will be estimated to measure inter-rater reliability and screening will begin when \>60% agreement is achieved.

Study selection will proceed according to the following: first, we will conduct a title and abstract screening. The full text of potentially relevant articles will be retrieved and screened in detail for relevance prior to data extraction. All screening, data extraction and quality assessment will be conducted in duplicate by (PD and JN). Disagreements will be resolved by consensus. When consensus cannot be reached, a third author will arbitrate (LM or LN).

Data extraction {#s2j}
---------------

We will extract bibliometric information such as author names, journal and year of publication, in addition to the location of the study, study design, number of participants, outcomes reported, outcome measures overall and outcome measures in French-speaking participants. For each outcome, measures of mean, SD or percent (95% CIs[@R23]) and where possible, measures of effect of the outcome in French-speaking people versus non-French speaking people (odds or risk ratios, mean differences, accompanied with 95% CIs) will also be extracted.

Assessment of methodological quality of the included studies {#s2k}
------------------------------------------------------------

Two authors will independently appraise the methodological quality of the studies using the Cochrane Risk of Bias Tool or the Newcastle-Ottawa Scale for randomised and non-randomised studies respectively.[@R24] Systematic reviews will be assessed using the Risk Of Bias in Systematic Review Tool [@R25] and the Assessing Quality of Systematic Reviews criteria.[@R26]

Analyses and reporting {#s2l}
----------------------

Our findings will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.[@R27] Our findings will be summarised narratively and using tables. Data will be grouped by outcomes, with the number of studies, their design and their methodological quality. Key findings of each study will also be summarised using tables. We will conduct a narrative synthesis of the data to identify common themes and knowledge gaps.

Discussion {#s3}
==========

The evidence of lack of French Language Healthcare Services in Ontario has been highlighted in previous research.[@R8] Stigma, discrimination and race are associated with poor HIV- care retention and access to care.[@R29] In this review we will answer important questions related to access to care for francophone ACB living in Canada. Furthermore, we will evaluate the impact of intersectionality of French language, race and HIV stigma on ACB accessibility to HIV care. The findings of this scoping systematic review will have implications for health policy making and how community organisations and HIV/AIDS centres provide care to Francophone ACB immigrants and Canadians.

One limitation of this scoping review is that it is focused only on Canada and, therefore, its global relevance is limited; however, theoretical generalisations can be postulated and tested with francophone diaspora minorities in predominantly Anglophone communities. Nonetheless, we will conduct a comprehensive exhaustive search, on a novel topic with an experienced research team.
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